Each year, drug companies funnel thousands of dollars through college campuses. They provide money for clinical research, for paying professors to speak at meetings, even money to buy pizza for med students. Does that money skew the science that's done on campus? Is there a conflict of interest?
Daniel S. Greenberg, science journalist; author of Science for Sale: The Perils, Rewards, and Delusions of Campus Capitalism
Eric G. Campbell, senior scientist and assistant professor at the Institute for Health Policy at Massachusetts General Hospital; associate professor of health policy at MGH Department of Medicine and Harvard Medical School
David Korn, senior vice president of the Association of American Medical Colleges
Marjorie Powell, senior assistant general counsel, Pharmaceutical Research and Manufacturers of America